- HER2 negative
- ER positive
- PD-L1 positive
- HER2 positive
- PR positive
- EGFR positive
- KRAS positive
- BRAF positive
- PD-L1 negative
- EGFR negative
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 2 or More Previous Chemotherapies
- >= 2 Bone Metastases (Untreated Lesion)
- ANC >= 1,500/mcL
- AST/ALT =< 3 x ULN
- Activating EGFR mutation [exon 19 deletion or exon 21 (L858R) substitution mutation]
- Adjuvant Therapy (except reconstruction)
- Anthracycline
- Anti-HER2 Therapy
- Endocrine Therapy
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
5482 trials
1
2
3
…50